CIPLA LTD. has reported financial results for the period ended September 30, 2020.
Financial Results (Q2 FY20-21) - QoQ Comparison
The company has reported total income of Rs.5091.76 crores during the period ended September 30, 2020 as compared to Rs.4411.61 crores during the period ended June 30, 2020.
The company has posted net profit / (loss) of Rs.665.43 crores for the period ended September 30, 2020 as against net profit / (loss) of Rs.577.91 crores for the period ended June 30, 2020.
The company has reported EPS of Rs.8.24 for the period ended September 30, 2020 as compared to Rs.7.16 for the period ended June 30, 2020.
|
Total Income | ₹ 5091.76 crs | ₹ 4411.61 crs | 15.42% |
Net Profit | ₹ 665.43 crs | ₹ 577.91 crs | 15.14% |
EPS | ₹ 8.24 | ₹ 7.16 | 15.08% |
Financial Results (Q2 FY20-21) - YoY ComparisonThe company has reported total income of Rs.5091.76 crores during the period ended September 30, 2020 as compared to Rs.4496.30 crores during the period ended September 30, 2019.
The company has posted net profit / (loss) of Rs.665.43 crores for the period ended September 30, 2020 as against net profit / (loss) of Rs.471.35 crores for the period ended September 30, 2019.
The company has reported EPS of Rs.8.24 for the period ended September 30, 2020 as compared to Rs.5.84 for the period ended September 30, 2019.
|
Total Income | ₹ 5091.76 crs | ₹ 4496.30 crs | 13.24% |
Net Profit | ₹ 665.43 crs | ₹ 471.35 crs | 41.18% |
EPS | ₹ 8.24 | ₹ 5.84 | 41.1% |
Financial Results (6 months ended FY 20-21) - YoY ComparisonThe company has reported total income of Rs.9503.37 crores during the 6 months period ended September 30, 2020 as compared to Rs.8563.69 crores during the 6 months period ended September 30, 2019.
The company has posted net profit / (loss) of Rs.1243.34 crores for the 6 months period ended September 30, 2020 as against net profit / (loss) of Rs.949.54 crores for the 6 months period ended September 30, 2019.
The company has reported EPS of Rs.15.40 for the 6 months period ended September 30, 2020 as compared to Rs.11.77 for the 6 months period ended September 30, 2019.
|
Total Income | ₹ 9503.37 crs | ₹ 8563.69 crs | 10.97% |
Net Profit | ₹ 1243.34 crs | ₹ 949.54 crs | 30.94% |
EPS | ₹ 15.40 | ₹11.77 | 30.84% |
Umang Vohra - MD and Global CEO, Cipla Ltd commented, "Pleased to see yet another quarter of strong performance across our businesses with overall revenues growing 15% on YoY basis. The performance reflects strong demand backed by resilient operations management. The quarter also saw sustained focus on cost optimization which helped deliver an EBITDA margin of over 23%. We continued to deliver on our promise of Caring for Life by being at the forefront in combatting COVID-19 through a spectrum of offerings, which also helped us deliver market beating performance in India. Our businesses in South Africa, US and other international markets maintained the growth momentum with strong traction in the base business and new launches. In line with our aspiration of being global lung leaders, we will continue our investment towards expanding our global respiratory franchise."
Shares of CIPLA LTD. was last trading in BSE at Rs.789.9 as compared to the previous close of Rs. 793.85. The total number of shares traded during the day was 233050 in over 6688 trades.
The stock hit an intraday high of Rs. 801.85 and intraday low of 786.6. The net turnover during the day was Rs. 184747848.
Source : Equity Bulls
Keywords